FOS and hepatocellular carcinoma: Persistent AP-1 activity, mediated by signalling pathways involving SIRT1, Jab1, and JNK/c-Yun, amplifies HBV replication and fosters an environment conducive to HCC development (Park et al., 2020; Tanaka et al., 2025).